Oral Fluid Analysis for Drivers Under the Influence of Drugs
DOI:
https://doi.org/10.17986/blm.2006111601Keywords:
madde etkisi altında taşıt sürme, yol üzeri madde testi, tükürükAbstract
The contribution of drugs to traffic accidents has been evaluated in a number of publications. In the last decade, several interesting development have occurred in the field of roadside testing for drugs. The need for a rapid, valid and suitable roadside test for the abused drugs focused the attention on alternative matrixes including oral fluid, urine and sweat, for detecting the drivers under the influence of drugs (DUID). European Union (EU)-project ROSITA (Road Side Testing Assessment) revealed that, a wide variety of illicit drugs can be found in different biological specimen of drivers where cannabis, opiates, amphetamine and its derivatives are those with the highest prevalence. Ege University and Head Council of Turkish Police coordinated and Cozart Bioscience Limited supported this project. The objectives of this project were to detect the usability and practicability of this test, besides revealing the possible problems during roadside drug testing encountered by the police. This study was performed on an experimental basis with voluntary participation of randomly selected drivers for the detection of abused drugs in street traffic, besides alcohol. They agreed to participate through informed consent. Oral fluid testing ( Cozart Rapiscan drug testing) for five panel drugs (Can-nabinoids, amphetamine, cocaine, opiates, benzodiazepines) was performed. 25 oral fluid samples were screened according to Cozart Bioscience instructions,. Confirmation was made by GC-MS. The oral fluid sample was positive for MDA at a concentration of 65 ng/mL and for MDMA at a concentration of 180 ng/mL. Key words: Driving under the influence of drugs (DUID), roadside drug testing, oral fluidDownloads
References
Krüger H P, Perine B M V, Mettke M, Huessy F Road traffic and illicit drugs, overview of the legal provisions, difficulties faced by the police , and analysis of prevention attempts in selected European countries. (1999) P-PG/Circrout (98) 4, Pompi- deou Group, Concil of Europe, Strasbourg /April.
Smink B E, Ruiter B, Lusthof K J and Zweipfen- ning PGM. Driving under the influence of alcohol and/or drugs in the Netherlands 1995-1998 in view of the German and Belgian legislation Forensic Science International. 2001; 120 (3):195-203. DOI: https://doi.org/10.1016/S0379-0738(00)00476-X
Bernhoft I M, A Steentoft, S S Johansen, N A Klit- gaard, L B Larsen and L B Hansen Drugs in injured drivers in Denmark. Forensic Science International. 2005; 150(10): 181-189. DOI: https://doi.org/10.1016/j.forsciint.2004.12.039
Deveaux M, Prangere R, Marson J, et al. The incidence of psychotropic drugs, opiates, and alcohol in fatally injured drivers: A prospective study in northern France J Anal Toxicol. 1996; 20:74
Mura P, Kintz , Ludes B, Gaulier JM, Marquet P, Martin-Dupont S, Vincent F, Kaddour A, Goulle JP> Nouveau J, moulsma M, tilhet-Coartet S and Pourrat O. Comparison of the prevalance of alcohol cannabis and other drugs between 900 injured drivers and 900 control subjects: Results of a french collborative study. Forensic Science International. 2003; 133:79-85. DOI: https://doi.org/10.1016/S0379-0738(03)00052-5
Drummer O H, Gerostamoulos G, Batziris H, Chu M, Caplehorn J, Robertson M D and Swann P. The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes Acc Anal & Prev. 2004; 36(2):239-248. DOI: https://doi.org/10.1016/S0001-4575(02)00153-7
http://www.hukuki.net/kanun/5237.15.text.asp Erişim Tarihi: 12.05.2006
EMCDDA,. National prevalence estimates of problem drug use in the European Union, 1995-2000. Final Report CT.00.RTX.23. Lisbon: European Monitoring Centre for Drugs and Drug Addiction. 2003.
EMCDDA Biomontly Newsletter of the European monitoring center for Drugs and Drug Addiction, Jan-Feb, Issue No:21.2004.
Toennes S W, Kauert G F, Steinmeyer S and Moeller M R. Driving under the influence of drugs— evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Science International 2005; 152(10):149-155 DOI: https://doi.org/10.1016/j.forsciint.2004.08.002
Verstraete A G, Oral fluid testing for driving under the influence of drugs: History, recent progress and remaining challenges Forensic Science International 2005; 150(10): 143-150. DOI: https://doi.org/10.1016/j.forsciint.2004.11.023
Choo R E and Huestis M A. Oral Fluid as a Diagnostic Tool. Clin Chem Lab Med 2004; 42(ll):1273-87. DOI: https://doi.org/10.1515/CCLM.2004.248
Cooper G, Wilson L, Reid C, Main L and Hand C. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid. Forensic Science International 2005; 150(10):239-243. DOI: https://doi.org/10.1016/j.forsciint.2004.12.042
Kintz P and Samyn N. Determination of "Ecstasy" components in alternative biological specimens. J. Chromatogr B: Biomed Sei and App 1999; 733: 137-143. DOI: https://doi.org/10.1016/S0378-4347(98)00521-0
Cooper G, Wilson L, Reid C, Hand C. and Spieh- ler V Validation of the Cozart® Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid. Forensic Science International 2006; 159:104-112. DOI: https://doi.org/10.1016/j.forsciint.2005.06.011
Downloads
Published
Issue
Section
License
The Journal and content of this website is licensed under the terms of the Creative Commons Attribution (CC BY) License. The Creative Commons Attribution License (CC BY) allows users to copy, distribute and transmit an article, adapt the article and make commercial use of the article. The CC BY license permits commercial and non-commercial re-use of an open access article, as long as the author is properly attributed.
